Introduction: The expression of specific miRNAs and their mRNA targets are changed in infectious disease. The aim of this study was to analyze the expression of pro-neuroinflammatory miRNAs, anti-neuroinflammatory miRNAs, and their mRNA targets in the serum of COVID-19 patients with different grades.
Methods: COVID-19 patients with different grades were enrolled in this study and the expression of pro-neuroinflammatory miRNAs, anti-neuroinflammatory miRNAs, and their target mRNAs was analyzed by q-PCR.
Results: The relative expression of anti- neuroinflammatory miRNAs (, , and ) was decreased and the relative expression of their target mRNAs (, , and ) was increased. Also, the relative expression of pro-neuroinflammatory miRNAs (, , and ) was increased and the relative expression of their target mRNA (, , and ) was decreased in COVID-19 patients with increase of disease grade. A negative significant correlation was seen between and mRNA, and mRNA, and mRNA, and mRNA, and mRNA, and between and mRNA in COVID-19 patients ( < 0.05).
Conclusions: This study showed that the relative expression of anti- neuroinflammatory miRNAs was decreased and the relative expression of their targeted mRNAs was increased in COVID-19 patients from asymptomatic to critical illness. Also, this study showed that the relative expression of pro-neuroinflammatory miRNAs was increased and the relative expression of their targeted mRNA was decreased in COVID-19 patients from asymptomatic to critical illness.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282440 | PMC |
http://dx.doi.org/10.1016/j.nrl.2021.06.005 | DOI Listing |
Hum Vaccin Immunother
December 2025
Sixth Form Department, Townley Grammar School, Bexleyheath, UK.
We explored adolescent viewpoints on vaccines and hesitancy using an anonymized, validated, self-completed electronic questionnaire amongst state-school Year 12-13 adolescents in London, UK. As the response rate was low (Cohort 1; = 112/486, 23.0%), we repeated the survey with incoming students (cohort 2, = 256/275; 93%).
View Article and Find Full Text PDFFront Pediatr
February 2025
International Research and Innovation in Medicine Program, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
Introduction: Recent studies have underscored the importance of genetic factors in predicting COVID-19 susceptibility and severity. While cytokine storms are crucial in disease severity, genetic predisposition significantly influences immune responses. Our study examined genes related to SARS-CoV-2 invasion ) and interferon-induced immunity ().
View Article and Find Full Text PDFFront Immunol
March 2025
Fundación Española para el Estudio y Terapéutica de la Enfermedad de Gaucher y otras lisosomales (FEETEG), Zaragoza, Spain.
Background: SARS-CoV-2 infection activates macrophages and induces the release of neutrophil extracellular traps (NETs). Excess NETs is linked to inflammatory and thrombotic complications observed in COVID-19.
Aim: To explore the impact of NETs and macrophage activation on SARS-CoV-2-infected patients who developed complications.
Indian J Otolaryngol Head Neck Surg
January 2025
Department of Dermatology, All India Institute of Medical Sciences, Raipur, India.
A Retroprospective observational study was conducted on Covid-19-associated mucormycosis (CAM) patients who underwent surgery at our institute. A total of 175 patients who met the inclusion and exclusion criteria were included in our study The study aimed to correlate the Overall survival and disease-specific survival rates with sites of involvement in patients with Covid Associated Mucormycosis and develop a novel prognostic classification of Mucormycosis. At the end of 24 months, the overall survival rate was 73.
View Article and Find Full Text PDFFront Neurol
February 2025
Department of Neurosurgery, University of Rochester Medical Center, Rochester, NY, United States.
Objectives: COVID-19 is an independent risk factor for ischemic stroke. Studies from early in the pandemic show increased rates of unfavorable recanalization, poor outcomes, and mortality in patients who were COVID-19 positive at the time of mechanical thrombectomy. However, there are currently no studies examining these parameters during the later pandemic when circulating variants were less virulent.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!